Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment

por Gambale, Elisabetta, Fancelli, Sara, Caliman, Enrico, Petrella, Maria Cristina, Doni, Laura, Pillozzi, Serena, Antonuzzo, Lorenzo
Publicado 2022

Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study

por Paderi, Agnese, Fancelli, Sara, Caliman, Enrico, Pillozzi, Serena, Gambale, Elisabetta, Mela, Marinella Micol, Doni, Laura, Mazzoni, Francesca, Antonuzzo, Lorenzo
Publicado 2021

Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

por Paderi, Agnese, Giorgione, Roberta, Giommoni, Elisa, Mela, Marinella Micol, Rossi, Virginia, Doni, Laura, Minervini, Andrea, Carini, Marco, Pillozzi, Serena, Antonuzzo, Lorenzo
Publicado 2021

Immune Checkpoint Inhibitors in the Treatment of Renal Cancer: Current State and Future Perspective

por Lavacchi, Daniele, Pellegrini, Elisa, Palmieri, Valeria Emma, Doni, Laura, Mela, Marinella Micol, Di Maida, Fabrizio, Amedei, Amedeo, Pillozzi, Serena, Carini, Marco, Antonuzzo, Lorenzo
Publicado 2020

Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?

por Rossi, Ernesto, Bersanelli, Melissa, Gelibter, Alain Jonathan, Borsellino, Nicolò, Caserta, Claudia, Doni, Laura, Maruzzo, Marco, Mosca, Alessandra, Pisano, Carmela, Verzoni, Elena, Zucali, Paolo Andrea
Publicado 2021

Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma

por Catalano, Martina, De Giorgi, Ugo, Maruzzo, Marco, Bimbatti, Davide, Buti, Sebastiano, Mazzaschi, Giulia, Procopio, Giuseppe, Santoni, Matteo, Galli, Luca, Conca, Raffaele, Doni, Laura, Antonuzzo, Lorenzo, Roviello, Giandomenico
Publicado 2022

Treatment of periocular advanced basal cell carcinoma with Hedgehog pathway inhibitors: A single-center study and a new dedicated therapeutic protocol

por De Giorgi, Vincenzo, Trane, Luciana, Pieretti, Giulia, Santoro, Nicola, Silvestri, Flavia, Venturi, Federico, Scarfì, Federica, Maio, Vincenza, Spinelli, Giuseppe, Scoccianti, Silvia, Guerrini, Laura, Massi, Daniela, Mazzini, Cinzia, Doni, Laura
Publicado 2021

Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy

por Becattini, Lucrezia, Saieva, Calogero, Doni, Laura, Roviello, Giandomenico, Spatafora, Pietro, Catalano, Martina, Sessa, Francesco, Galli, Ilaria Camilla, Bisegna, Claudio, Conte, Francesco Lupo, Zaccaro, Claudia, Santi, Raffaella, Serni, Sergio, Nesi, Gabriella, Villari, Donata
Publicado 2022

Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors

por Roviello, Giandomenico, Catalano, Martina, De Giorgi, Ugo, Maruzzo, Marco, Buti, Sebastiano, Gambale, Elisabetta, Procopio, Giuseppe, Ottanelli, Carlotta, Caliman, Enrico, Isella, Luca, Sepe, Pierangela, Brighi, Nicole, Santoni, Matteo, Galli, Luca, Conca, Raffaele, Doni, Laura, Antonuzzo, Lorenzo
Publicado 2022

Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01–2014)

por Passalacqua, Rodolfo, Lazzarelli, Silvia, Donini, Maddalena, Montironi, Rodolfo, Tambaro, Rosa, De Giorgi, Ugo, Pignata, Sandro, Palumbo, Raffaella, Ceresoli, Giovanni Luca, Del Conte, Gianluca, Tonini, Giuseppe, Morelli, Franco, Nolè, Franco, Panni, Stefano, Rondini, Ermanno, Guida, Annalisa, Zucali, Paolo Andrea, Doni, Laura, Iezzi, Elisa, Caminiti, Caterina
Publicado 2017

Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet‐Uro 19BEYOND study

por Roviello, Giandomenico, Gambale, Elisabetta, Giorgione, Roberta, Santini, Daniele, Stellato, Marco, Fornarini, Giuseppe, Rebuzzi, Sara Elena, Basso, Umberto, Bimbatti, Davide, Doni, Laura, Nesi, Gabriella, Bersanelli, Melissa, Buti, Sebastiano, De Giorgi, Ugo, Galli, Luca, Sbrana, Andrea, Conca, Raffaele, Carella, Claudia, Naglieri, Emanuele, Pignata, Sandro, Procopio, Giuseppe, Antonuzzo, Lorenzo
Publicado 2022

A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOI...

por Procopio, Giuseppe, Claps, Mélanie, Pircher, Chiara, Porcu, Luca, Sepe, Pierangela, Guadalupi, Valentina, De Giorgi, Ugo, Bimbatti, Davide, Nolè, Franco, Carrozza, Francesco, Buti, Sebastiano, Iacovelli, Roberto, Ciccarese, Chiara, Masini, Cristina, Baldessari, Cinzia, Doni, Laura, Cusmai, Antonio, Gernone, Angela, Scagliarini, Sarah, Pignata, Sandro, de Braud, Filippo, Verzoni, Elena
Publicado 2022

Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study

por Berardi, Rossana, Mastroianni, Candida, Lo Russo, Giuseppe, Buosi, Roberta, Santini, Daniele, Montanino, Agnese, Carnaghi, Carlo, Tiseo, Marcello, Chiari, Rita, Camerini, Andrea, Barni, Sandro, De Marino, Valeria, Ferrari, Daris, Cristofano, Antonella, Doni, Laura, Freddari, Federica, Fumagalli, Daniele, Portalone, Luigi, Sarmiento, Roberta, Schinzari, Giovanni, Sperandi, Francesca, Tucci, Marcello, Inno, Alessandro, Ciuffreda, Libero, Mariotti, Marita, Mariani, Cinzia, Caramanti, Miriam, Torniai, Mariangela, Gallucci, Rosaria, Bennati, Chiara, Bordi, Paola, Buffoni, Lucio, Galeassi, Achille, Ghidini, Michele, Grossi, Emidio, Morabito, Alessandro, Vincenzi, Bruno, Arvat, Emanuela
Publicado 2019